{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:43:45Z","timestamp":1794624225151,"version":"4.9.1"},"reference-count":204,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019345","name":"King Salman Center for Disability Research","doi-asserted-by":"publisher","award":["KSRG-2022-073"],"award-info":[{"award-number":["KSRG-2022-073"]}],"id":[{"id":"10.13039\/501100019345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijbiomac.2024.135761","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:58:40Z","timestamp":1726851520000},"page":"135761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"P2","title":["Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities"],"prefix":"10.1016","volume":"280","author":[{"given":"Saheem","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Faizan Ali","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Alouffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahvish","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Wajid Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan Ahmad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijbiomac.2024.135761_bb0005","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3390\/ijms22147644","article-title":"Diabetes mellitus and its metabolic complications: the role of adipose tissues","volume":"22","author":"Dilworth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.135761_bb0010","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1254\/jphs.08071FP","article-title":"Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats","volume":"107","author":"Matsumoto","year":"2008","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1389557515666150909143737","article-title":"Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases","volume":"16","author":"Grewal","year":"2015","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0025","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0030","series-title":"Diabetes Atlas","author":"International Diabetes Federation (IDF)","year":"2021"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5001\/omj.2017.34","article-title":"Diabetes mellitus: a local and global public health emergency!","volume":"32","author":"Al-Lawati","year":"2017","journal-title":"Oman Med. J."},{"issue":"December","key":"10.1016\/j.ijbiomac.2024.135761_bb0040","article-title":"Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/dc09-2326","article-title":"Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the European prospective investigation of cancer\u2014Norfolk cohort","volume":"34","author":"Chamnan","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes mellitus, the fastest growing global public health concern: early detection should be focused","volume":"7","author":"Hossain","year":"2024","journal-title":"Health Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/2230-8210.107825","article-title":"Expanding role of the Madras Diabetes Research Foundation \u2014 Indian diabetes risk score in clinical practice","volume":"17","author":"Mohan","year":"2013","journal-title":"Ind. J. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5001\/omj.2012.68","article-title":"Type 2 diabetes mellitus: a review of current trends","volume":"27","author":"Olokoba","year":"2012","journal-title":"Oman Med. J."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9922","key":"10.1016\/j.ijbiomac.2024.135761_bb0075","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1179\/acb.2003.58.6.001","article-title":"Pathophysiology of type 2 diabetes","volume":"58","author":"Scheen","year":"2003","journal-title":"Acta Clin. Belg."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-019-0097-9","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4062\/biomolther.2020.204","article-title":"Diabetic nephropathy \u2014 a review of risk factors, progression, mechanism, and dietary management","volume":"29","author":"Natesan","year":"2021","journal-title":"Biomol. Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0095","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41374-019-0264-3","article-title":"Vascular changes in diabetic retinopathy\u2014a longitudinal study in the Nile rat","volume":"99","author":"Toh","year":"2019","journal-title":"Lab. Investig."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of diabetes and diabetes-related complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin. Diabetes"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ame2.12001","article-title":"Redox imbalance stress in diabetes mellitus: role of the polyol pathway","volume":"1","author":"Yan","year":"2018","journal-title":"Anim. Models Exp. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0115","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/13813455.2021.1874996","article-title":"Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats","volume":"129","author":"Nabi","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0120","first-page":"442","article-title":"Differential impact of glycation on apolipoprotein AI of high-density lipoprotein: a review","volume":"33","author":"Maarfi","year":"2023","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0125","first-page":"62","article-title":"Correction: Yu et al. Inhibiting liver autophagy and promoting hepatocyte apoptosis by Schistosoma japonicum infection. Trop. Med. Infect. Dis. 2024, 9, 42","volume":"9","author":"Yu","year":"2024","journal-title":"Trop. Med. Infect. Dis."},{"issue":"6865","key":"10.1016\/j.ijbiomac.2024.135761_bb0130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0135","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"March","key":"10.1016\/j.ijbiomac.2024.135761_bb0140","article-title":"Aldose reductase: an emerging target for development of interventions for diabetic cardiovascular complications","volume":"12","author":"Jannapureddy","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"issue":"January","key":"10.1016\/j.ijbiomac.2024.135761_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0009-2797(00)00295-7","article-title":"The aldo-keto reductase (AKR) superfamily: an update","volume":"130\u2013132","author":"Jez","year":"2001","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCRESAHA.109.213447","article-title":"Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model","volume":"106","author":"Ramasamy","year":"2010","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/138945008783431781","article-title":"Aldose reductase, still a compelling target for diabetic neuropathy","volume":"9","author":"Oates","year":"2008","journal-title":"Curr. Drug Targets"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0165","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/13543776.2012.726615","article-title":"Novel aldose reductase inhibitors: a patent survey (2006\u2013present)","volume":"22","author":"Chatzopoulou","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"issue":"suppl_3","key":"10.1016\/j.ijbiomac.2024.135761_bb0170","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1097\/01.ASN.0000077408.15865.06","article-title":"Contribution of polyol pathway to diabetes-induced oxidative stress","volume":"14","author":"Chung","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.135761_bb0175","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2174\/0929867033457377","article-title":"Recent studies of aldose reductase enzyme inhibition for diabetic complications","volume":"10","author":"Suzen","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0180","article-title":"Vitamin D supplementation modulates glycated hemoglobin (HBA1c) in diabetes mellitus","volume":"109911","author":"Akhter","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0185","first-page":"1986","article-title":"Identification of glycoxidative lesion in isolated low-density lipoproteins from diabetes mellitus subjects","volume":"13","author":"Alyahyawi","year":"2023","journal-title":"Life (Basel, Switzerland)"},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0190","doi-asserted-by":"crossref","first-page":"106014","DOI":"10.1016\/j.fitote.2024.106014","article-title":"Phytoconstituents of Nymphaea rubra flowers and their anti-diabetic metabolic targets","author":"Ishrat","year":"2024","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0195","article-title":"Generation of autoantibodies against glycated fibrinogen: role in diabetic nephropathy and retinopathy","volume":"115393","author":"Khanam","year":"2023","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10930-024-10191-3","article-title":"The complex landscape of intracellular signalling in protein modification under hyperglycaemic stress leading to metabolic disorders","volume":"43","author":"Khan","year":"2024","journal-title":"Protein J."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2024.135761_bb0205","doi-asserted-by":"crossref","first-page":"133816","DOI":"10.1016\/j.ijbiomac.2024.133816","article-title":"Aldose reductase inhibitory and antiglycation properties of phytoconstituents of Cichorium intybus: potential therapeutic role in diabetic retinopathy","volume":"277","author":"Ahmad","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0210","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0215","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/ATVBAHA.107.158295","article-title":"Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis","volume":"28","author":"Gleissner","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00087","article-title":"Aldose reductase, oxidative stress, and diabetic mellitus","volume":"3","author":"Tang","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1389450054021891","article-title":"Aldose reductase in diabetic microvascular complications","volume":"6","author":"Chung","year":"2005","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/dmrr.1075","article-title":"Diabetic cataracts: mechanisms and management","volume":"26","author":"Obrosova","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0235","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/er.2004-0028","article-title":"Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options","volume":"26","author":"Srivastava","year":"2005","journal-title":"Endocr. Rev."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.135761_bb0240","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.113.005224","article-title":"Aldose reductase-mediated phosphorylation of P53 leads to mitochondrial dysfunction and damage in diabetic platelets","volume":"129","author":"Tang","year":"2014","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.135761_bb0245","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.3390\/jcm12237349","article-title":"Pathomechanisms of diabetic kidney disease","volume":"12","author":"Sinha","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0250","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1751731119002337","article-title":"Dietary phytase and myo-inositol supplementation are associated with distinct plasma metabolome profile in broiler chickens","volume":"14","author":"Gonzalez-Uarquin","year":"2020","journal-title":"Animal"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0255","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s00018-005-5024-4","article-title":"Phorbol ester up-regulates aldose reductase expression in A549 cells: a potential role for aldose reductase in cell cycle modulation","volume":"62","author":"Kang","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"issue":"7884","key":"10.1016\/j.ijbiomac.2024.135761_bb0260","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41586-021-04049-2","article-title":"Low glycaemic diets alter lipid metabolism to influence tumour growth","volume":"599","author":"Lien","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8227(95)01055-I","article-title":"The effect of non-enzymatic glycation on recombinant human aldose reductase","volume":"27","author":"Yamaoka","year":"1995","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0270","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.1996.1695","article-title":"Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway","volume":"228","author":"Hamada","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"January","key":"10.1016\/j.ijbiomac.2024.135761_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/343560","article-title":"Pathophysiology of diabetic retinopathy","volume":"2013","author":"Tarr","year":"2013","journal-title":"ISRN Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0280","first-page":"1","article-title":"Aldose reductase inhibitory activity of compounds from Zea mays L","volume":"2013","author":"Kim","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138945009787122905","article-title":"Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy \u2014 are these receptors valid therapeutic targets","volume":"10","author":"Sourris","year":"2009","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0290","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s001250050916","article-title":"An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor? And protein kinase C activity in cultured human mesangial cells","volume":"41","author":"Ishii","year":"1998","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMra1701695","article-title":"Metastatic prostate cancer","volume":"378","author":"Sartor","year":"2018","journal-title":"New Engl. J. Med."},{"issue":"02","key":"10.1016\/j.ijbiomac.2024.135761_bb0300","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2007-949721","article-title":"Diabetic nephropathy: where hemodynamics meets metabolism","volume":"115","author":"Forbes","year":"2007","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0305","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1464-5491.2004.01259.x","article-title":"Association of aldose reductase gene Z\u00a0+\u00a02 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian type 1 diabetic patients","volume":"21","author":"Lajer","year":"2004","journal-title":"Diabet. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0310","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00125-023-05964-x","article-title":"Genetics of diabetes-associated microvascular complications","volume":"66","author":"Lyssenko","year":"2023","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0315","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.2337\/diabetes.53.11.2984","article-title":"Association of glomerulopathy with the 5\u2032-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients","volume":"53","author":"Zhao","year":"2004","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0320","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/JME-07-0152","article-title":"Association between (AC)n dinucleotide repeat polymorphism at the 5\u2032-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis","volume":"40","author":"Xu","year":"2008","journal-title":"J. Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0325","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/diacare.16.5.789","article-title":"Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy","volume":"16","author":"Passariello","year":"1993","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0330","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1056-8727(01)00160-X","article-title":"Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in type 2 diabetic patients","volume":"15","author":"Iso","year":"2001","journal-title":"J. Diabetes Complicat."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0335","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/diacare.23.10.1539","article-title":"Epalrestat, an aldose reductase inhibitor, reduces the levels of nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients","volume":"23","author":"Hamada","year":"2000","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0340","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1517\/14728214.2010.512610","article-title":"Emerging drugs for diabetic neuropathy","volume":"15","author":"Tahrani","year":"2010","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-118-1-199301010-00002","article-title":"Tolrestat for mild diabetic neuropathy: a 52-week, randomized, placebo-controlled trial","volume":"118","author":"Giugliano","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0350","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/dc08-2110","article-title":"Ranirestat for the management of diabetic sensorimotor polyneuropathy","volume":"32","author":"Bril","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0355","article-title":"Aldose reductase inhibitors for the treatment of diabetic polyneuropathy","volume":"2010","author":"Chalk","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0360","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/diabetes.54.1.234","article-title":"Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications","volume":"54","author":"Obrosova","year":"2005","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0365","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/jm701514k","article-title":"Unusual binding mode of the 2S4R stereoisomer of the potent aldose reductase cyclic imide inhibitor fidarestat (2S4S) in the 15\u00a0K crystal structure of the ternary complex refined at 0.78\u00a0\u00c5 resolution: implications for the inhibition mechanism","volume":"51","author":"Zhao","year":"2008","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0370","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/diagnostics12030731","article-title":"Is nerve electrophysiology a robust primary endpoint in clinical trials of treatments for diabetic peripheral neuropathy?","volume":"12","author":"Al-Bazz","year":"2022","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0375","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.2337\/diacare.24.10.1776","article-title":"Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy","volume":"24","author":"Hotta","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0380","series-title":"Diabetes Mellitus \u2014 Insights and Perspectives","article-title":"Aldose reductase inhibitors as potential therapeutic drugs of diabetic complications","author":"Zhu","year":"2013"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0385","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/jdi.12890","article-title":"Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: a randomized double-blind placebo-controlled study in Japan","volume":"10","author":"Sekiguchi","year":"2019","journal-title":"J. Diab. Investig."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/1056-8727(93)90041-V","article-title":"Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy","volume":"7","author":"Sima","year":"1993","journal-title":"J. Diabetes Complicat."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0395","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ardp.200600166","article-title":"Novel aldose reductase inhibitors derived from 6-[[(diphenylmethylene)amino]oxy]hexanoic acid","volume":"340","author":"Rakowitz","year":"2007","journal-title":"Arch. Pharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0400","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.oret.2020.02.003","article-title":"Aflibercept reduces retinal hemorrhages and intravitreal microvascular abnormalities but not venous beading","volume":"4","author":"Pearce","year":"2020","journal-title":"Ophthalmol. Ret."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0405","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2337\/dc16-1728","article-title":"Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association","volume":"39","author":"Colberg","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0410","article-title":"Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy","volume":"2023","author":"Perais","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0415","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0014-4835(90)90104-3","article-title":"Current progress in clinical trials of aldose reductase inhibitors in Japan","volume":"50","author":"Hotta","year":"1990","journal-title":"Exp. Eye Res."},{"issue":"January","key":"10.1016\/j.ijbiomac.2024.135761_bb0420","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.biopha.2018.10.185","article-title":"A non-invasive, multi-target approach to treat diabetic retinopathy","volume":"109","author":"Julius","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0425","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00154405","article-title":"Cone electroretinograms and visual acuities of diabetic patients on sorbinil treatment","volume":"69","author":"Biersdorf","year":"1988","journal-title":"Doc. Ophthalmol."},{"issue":"March","key":"10.1016\/j.ijbiomac.2024.135761_bb0430","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2147\/OPTH.S351790","article-title":"Validation of an algorithm for the prediction of diabetic retinopathy in type 1 diabetic patients in a Spanish population","volume":"16","author":"Romero-Aroca","year":"2022","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0435","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-4835(90)90211-C","article-title":"Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening\u2014prevention by an aldose reductase inhibitor","volume":"50","author":"Das","year":"1990","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0440","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11892-017-0913-0","article-title":"Animal models of diabetic retinopathy","volume":"17","author":"Olivares","year":"2017","journal-title":"Curr. Diab. Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0445","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S2213-8587(23)00128-6","article-title":"Predicting and preventing heart failure in type 2 diabetes","volume":"11","author":"Pandey","year":"2023","journal-title":"Lancet Diab. Endocrinol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0450","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1242\/dmm.009597","article-title":"Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals","volume":"5","author":"Robinson","year":"2012","journal-title":"Dis. Model. Mech."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0455","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archopht.1990.01070110117035","article-title":"Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors","volume":"108","author":"Kador","year":"1990","journal-title":"Arch. Ophthalmol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0460","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3390\/biomedicines11102852","article-title":"Animal models in diabetic research\u2014history, presence, and future perspectives","volume":"11","author":"Pandey","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0465","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14826","article-title":"Diabetes mellitus and its association with dental caries, missing teeth and dental services utilization in the US adult population: results from the 2015\u20132018 National Health and Nutrition Examination Survey","volume":"39","author":"Aldosari","year":"2022","journal-title":"Diabet. Med."},{"issue":"February","key":"10.1016\/j.ijbiomac.2024.135761_bb0470","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0009-2797(02)00191-6","article-title":"Role of aldose reductase in TNF-\u03b1-induced apoptosis of vascular endothelial cells","volume":"143\u2013144","author":"Chandra","year":"2003","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0475","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.ATV.20.7.1745","article-title":"Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury","volume":"20","author":"Ruef","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0480","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1096\/fj.03-1400com","article-title":"Central role for aldose reductase pathway in myocardial ischemic injury","volume":"18","author":"Hwang","year":"2004","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0485","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/acm.2013.0088","article-title":"Alkaloids as aldose reductase inhibitors, with special reference to berberine","volume":"20","author":"Gupta","year":"2014","journal-title":"J. Altern. Complement. Med."},{"issue":"35","key":"10.1016\/j.ijbiomac.2024.135761_bb0490","doi-asserted-by":"crossref","first-page":"32063","DOI":"10.1074\/jbc.M202126200","article-title":"Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells","volume":"277","author":"Ramana","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0495","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCRESAHA.109.200568","article-title":"Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice","volume":"105","author":"Srivastava","year":"2009","journal-title":"Circ. Res."},{"issue":"October","key":"10.1016\/j.ijbiomac.2024.135761_bb0500","article-title":"An alternative biomimetic tool \u2014 dual hydrophilic\/reversed-phase interaction mode","volume":"193","author":"Obradovi\u0107","year":"2023","journal-title":"Microchem. J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0505","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/diab.40.11.1560","article-title":"Effect of diabetes on cytosolic free Ca2+ and Na+-K+-ATPase in rat aorta","volume":"40","author":"Ohara","year":"1991","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0510","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2337\/diab.42.11.1594","article-title":"Effects of high glucose concentrations and epalrestat on sorbitol and myo-inositol metabolism in cultured rabbit aortic smooth muscle cells","volume":"42","author":"Sakakibara","year":"1993","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0515","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1113\/jphysiol.2014.282319","article-title":"Na+\/Ca2+ exchange and Na+\/K+-ATPase in the heart","volume":"593","author":"Shattock","year":"2015","journal-title":"J. Physiol."},{"issue":"supp5","key":"10.1016\/j.ijbiomac.2024.135761_bb0520","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ndt\/11.supp5.95","article-title":"Role of polyol pathway in nonenzymatic glycation","volume":"11","author":"Hamada","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.135761_bb0525","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s001250051310","article-title":"An aldose reductase inhibitor prevents the intimal thickening in coronary arteries of galactose-fed beagle dogs","volume":"42","author":"Kasuya","year":"1999","journal-title":"Diabetologia"},{"issue":"February","key":"10.1016\/j.ijbiomac.2024.135761_bb0530","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0021-9258(17)45256-2","article-title":"Isolation and properties of lens aldose reductase","volume":"240","author":"Hayman","year":"1965","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0535","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1021\/jm00145a001","article-title":"Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications","volume":"28","author":"Kador","year":"1985","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0540","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/jm00369a003","article-title":"N-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-N-methylglycine (tolrestat), a potent, orally active aldose reductase inhibitor","volume":"27","author":"Sestanj","year":"1984","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0545","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0026-0495(91)90196-4","article-title":"Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat","volume":"40","author":"Ao","year":"1991","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0550","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/jm00105a018","article-title":"Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid (zopolrestat) and congeners","volume":"34","author":"Mylari","year":"1991","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.135761_bb0555","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1021\/jm050382p","article-title":"Naphtho[1,2-d]isothiazole acetic acid derivatives as a novel class of selective aldose reductase inhibitors","volume":"48","author":"Da Settimo","year":"2005","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0560","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00024677-200403040-00006","article-title":"Clinical potential of aldose reductase inhibitors in diabetic neuropathy","volume":"3","author":"Hamada","year":"2004","journal-title":"Treat. Endocrinol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0565","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00044011-199815020-00005","article-title":"Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy","volume":"15","author":"Didangelos","year":"1998","journal-title":"Clin. Drug Investig."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0570","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00404095","article-title":"A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy","volume":"33","author":"Boulton","year":"1990","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0575","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1592\/phco.28.5.646","article-title":"Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy","volume":"28","author":"Ramirez","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0580","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1464-5491.2008.02490.x","article-title":"Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat","volume":"25","author":"Hotta","year":"2008","journal-title":"Diabet. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0585","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jdiacomp.2008.10.005","article-title":"Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N\u025b-carboxymethyl lysine","volume":"24","author":"Kawai","year":"2010","journal-title":"J. Diabetes Complicat."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0590","first-page":"313","article-title":"Altering the course of cataracts in diabetic rats","volume":"19","author":"Fukushi","year":"1980","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.135761_bb0595","first-page":"2368","article-title":"Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model","volume":"36","author":"Robison","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0600","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0969-2126(97)00216-5","article-title":"A \u2018specificity\u2019 pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil","volume":"5","author":"Urzhumtsev","year":"1997","journal-title":"Structure (Lond., Engl.)"},{"issue":"5A","key":"10.1016\/j.ijbiomac.2024.135761_bb0605","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(85)90507-8","article-title":"Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy","volume":"79","author":"Jaspan","year":"1985","journal-title":"Am. J. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0610","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/0003-4819-114-9-720","article-title":"In-vitro assessment of a hypersensitivity syndrome associated with sorbinil","volume":"114","author":"Spielberg","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"35","key":"10.1016\/j.ijbiomac.2024.135761_bb0615","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1021\/bi00035a036","article-title":"Mechanism of human aldehyde reductase: characterization of the active site pocket","volume":"34","author":"Barski","year":"1995","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.135761_bb0620","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1021\/jm9802968","article-title":"Novel, highly potent aldose reductase inhibitors: (R)-(\u2212)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3\u2032-pyrrolidine-1,2\u2032,3,5\u2032-tetrone (AS-3201) and its congeners","volume":"41","author":"Negoro","year":"1998","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0625","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1056-8727(01)00175-1","article-title":"Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients","volume":"16","author":"Asano","year":"2002","journal-title":"J. Diabetes Complicat."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0630","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bcp.2005.10.036","article-title":"Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability","volume":"71","author":"Kurono","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0635","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1254\/jphs.08061FP","article-title":"Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats","volume":"107","author":"Matsumoto","year":"2008","journal-title":"J. Pharmacol. Sci."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.135761_bb0640","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/0006-2952(87)90266-8","article-title":"Development of potent aldose reductase inhibitors having a hydantoin structure","volume":"36","author":"Miwa","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0645","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-2952(90)90692-E","article-title":"In vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure","volume":"40","author":"Miwa","year":"1990","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0650","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1248\/cpb.39.1540","article-title":"Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and Sorbinil","volume":"39","author":"Kato","year":"1991","journal-title":"Chem. Pharm. Bull."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0655","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2337\/db06-0138","article-title":"A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy","volume":"55","author":"Sun","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0660","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/1940-6207.CAPR-15-0306","article-title":"Piperlongumine suppresses growth and sensitizes pancreatic tumors to gemcitabine in a xenograft mouse model by modulating the NF-kappa B pathway","volume":"9","author":"Wang","year":"2016","journal-title":"Cancer Prev. Res."},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.135761_bb0665","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1021\/jm070398a","article-title":"Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity","volume":"50","author":"La Motta","year":"2007","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0670","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-0495(96)90285-1","article-title":"An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats","volume":"45","author":"Berti-Mattera","year":"1996","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.01-0603fje","article-title":"An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense","volume":"16","author":"Obrosova","year":"2002","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0680","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/db05-1433","article-title":"Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic neuropathy","volume":"55","author":"Demiot","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.135761_bb0685","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s00125-006-0400-7","article-title":"Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat","volume":"49","author":"Kuzumoto","year":"2006","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0690","first-page":"916","article-title":"Drug evaluation: ranirestat\u2014an aldose reductase inhibitor for the potential treatment of diabetic complications","volume":"7","author":"Giannoukakis","year":"2006","journal-title":"Curr. Opin. Investig. Drugs (Lond., Engl.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0695","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2337\/diacare.29.01.06.dc05-1447","article-title":"Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy","volume":"29","author":"Bril","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0700","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/diacare.27.2.448","article-title":"Cardiac abnormalities in diabetic patients with neuropathy","volume":"27","author":"Johnson","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0705","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.53.3.580","article-title":"Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat study group","volume":"53","author":"Greene","year":"1999","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0710","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1053\/meta.2000.17723","article-title":"The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats","volume":"49","author":"Shimoshige","year":"2000","journal-title":"Metab. Clin. Exp."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2024.135761_bb0715","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)02052-3","article-title":"Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat","volume":"310","author":"Kihara","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"January","key":"10.1016\/j.ijbiomac.2024.135761_bb0720","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2008.10.018","article-title":"Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats","volume":"1247","author":"Shimoshige","year":"2009","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0725","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/diacare.27.5.1153","article-title":"Natural progression of diabetic peripheral neuropathy in the zenarestat study population","volume":"27","author":"Brown","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0730","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mus.20577","article-title":"Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial","volume":"34","author":"Bird","year":"2006","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0735","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1021\/np0503698","article-title":"Phenolic marine natural products as aldose reductase inhibitors","volume":"69","author":"Manzanaro","year":"2006","journal-title":"J. Nat. Prod."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0740","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.patbio.2006.07.006","article-title":"Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes","volume":"54","author":"Peyroux","year":"2006","journal-title":"Pathol. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0745","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1350-9462(97)00013-X","article-title":"Aldose reductase: a window to the treatment of diabetic complications?","volume":"17","author":"Crabbe","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0750","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1039\/b204709h","article-title":"Aldose reductase inhibitors from natural sources","volume":"20","author":"de la Fuente","year":"2003","journal-title":"Nat. Prod. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0755","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12011-018-1443-6","article-title":"Protective effect of hesperidin on sodium arsenite-induced nephrotoxicity and hepatotoxicity in rats","volume":"189","author":"Turk","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"issue":"May","key":"10.1016\/j.ijbiomac.2024.135761_bb0760","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijbiomac.2017.01.129","article-title":"Inhibition of glycation and aldose reductase activity using dietary flavonoids: a lens organ culture studies","volume":"98","author":"Patil","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.135761_bb0765","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-7847.194044","article-title":"Overviews of biological importance of quercetin: a bioactive flavonoid","volume":"10","author":"David","year":"2016","journal-title":"Pharmacogn. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0770","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3892\/mmr.2012.1253","article-title":"Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells","volume":"7","author":"Daker","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"4274","key":"10.1016\/j.ijbiomac.2024.135761_bb0775","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1126\/science.401544","article-title":"Diabetic cataracts and flavonoids","volume":"195","author":"Varma","year":"1977","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0780","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3839\/jabc.2017.006","article-title":"Aldose reductase inhibitory activity of quercetin from the stems of Rhododendron mucronulatum for. albiflorum","volume":"60","author":"Lee","year":"2017","journal-title":"J. Appl. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0785","doi-asserted-by":"crossref","DOI":"10.2478\/s11696-012-0240-5","article-title":"Novel quercetin derivatives: synthesis and screening for anti-oxidant activity and aldose reductase inhibition","volume":"67","author":"Veverka","year":"2013","journal-title":"Chem. Pap."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0790","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1021\/acsnano.9b01346","article-title":"Natural berberine-based Chinese herb medicine assembled nanostructures with modified antibacterial application","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0795","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/cells9051233","article-title":"The influence of palmatine isolated from Berberis sibirica Radix on pentylenetetrazole-induced seizures in zebrafish","volume":"9","author":"Gawel","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0800","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/13880209.2019.1577466","article-title":"Coptidis rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology","volume":"57","author":"Wang","year":"2019","journal-title":"Pharm. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0805","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"issue":"December","key":"10.1016\/j.ijbiomac.2024.135761_bb0810","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lfs.2016.09.025","article-title":"Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance","volume":"166","author":"Ye","year":"2016","journal-title":"Life Sci."},{"issue":"January","key":"10.1016\/j.ijbiomac.2024.135761_bb0815","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2018.10.453","article-title":"Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity","volume":"130","author":"Paul","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0820","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/03602530903118729","article-title":"New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme","volume":"41","author":"Wang","year":"2009","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0825","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/np50032a014","article-title":"Flavonoids with anti-cataract activity from Brickellia arguta","volume":"47","author":"Rosler","year":"1984","journal-title":"J. Nat. Prod."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0830","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1248\/cpb.37.3153","article-title":"Studies on lens-aldose-reductase inhibitor in medicinal plants. II. Active constituents of Monochasma savatierii Franch. et maxim","volume":"37","author":"Kohda","year":"1989","journal-title":"Chem. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0835","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1248\/cpb.43.1385","article-title":"Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation","volume":"43","author":"Okada","year":"1995","journal-title":"Chem. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0840","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1248\/cpb.47.340","article-title":"Medicinal flowers. I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C, from the flowers of Chrysanthemum indicum L","volume":"47","author":"Yoshikawa","year":"1999","journal-title":"Chem. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0845","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/fstl.1994.1085","article-title":"Aldose reductase inhibitors from green tea","volume":"27","author":"Murata","year":"1994","journal-title":"LWT Food Sci. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0850","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF02976631","article-title":"Isoflavonoids from the rhizomes of Belamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues","volume":"25","author":"Jung","year":"2002","journal-title":"Arch. Pharm. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.135761_bb0855","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1248\/cpb.50.972","article-title":"Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase","volume":"50","author":"Matsuda","year":"2002","journal-title":"Chem. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0860","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/s-2003-43218","article-title":"A flavone from Manilkara indica as a specific inhibitor against aldose reductase in vitro","volume":"69","author":"Haraguchi","year":"2003","journal-title":"Planta Med."},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2024.135761_bb0865","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.phymed.2003.12.002","article-title":"Aldose reductase inhibitors from the leaves of Myrciaria dubia (H. B. & K.) McVaugh","volume":"11","author":"Ueda","year":"2004","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.135761_bb0870","first-page":"41","article-title":"Inhibitory activity of flavonoids on the lens aldose reductase of healthy and diabetic rats","volume":"44","author":"Goodarzi","year":"2006","journal-title":"Acta Med. Iran."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.135761_bb0875","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.phytochem.2006.05.015","article-title":"Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus","volume":"67","author":"Logendra","year":"2006","journal-title":"Phytochemistry"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0880","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ardp.200500205","article-title":"Curcumin analogs as potent aldose reductase inhibitors","volume":"339","author":"Du","year":"2006","journal-title":"Arch. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.135761_bb0885","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ptr.1847","article-title":"Rat lens aldose reductase inhibitory constituents of Nelumbo nucifera stamens","volume":"20","author":"Lim","year":"2006","journal-title":"Phytother. Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.135761_bb0890","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1016\/j.fct.2008.10.004","article-title":"Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress","volume":"46","author":"Jung","year":"2008","journal-title":"Food Chem. Toxicol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.135761_bb0895","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.1016\/j.bmc.2006.07.002","article-title":"Aldose reductase inhibitory effect by tectorigenin derivatives from Viola hondoensis","volume":"14","author":"Moon","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.135761_bb0900","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1021\/jf061599a","article-title":"Inhibitory effects of Zingiber officinale Roscoe derived components on aldose reductase activity in vitro and in vivo","volume":"54","author":"Kato","year":"2006","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0905","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.foodchem.2006.04.016","article-title":"Identification of phenolic compounds isolated from pigmented rices and their aldose reductase inhibitory activities","volume":"101","author":"Yawadio","year":"2007","journal-title":"Food Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0910","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1248\/bpb.30.1569","article-title":"Aldose reductase and advanced glycation endproducts inhibitory effect of Phyllostachys nigra","volume":"30","author":"Jung","year":"2007","journal-title":"Biol. Pharm. Bull."},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.135761_bb0915","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1016\/j.bmc.2008.10.003","article-title":"Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols","volume":"16","author":"Chethan","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.135761_bb0920","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/14756360802560867","article-title":"Aldose reductase inhibitors from Litchi chinensis Sonn","volume":"24","author":"Lee","year":"2009","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135761_bb0925","first-page":"3","article-title":"Structure-activity relationships of components from the roots of Pueraria thunbergiana having aldose reductase inhibitory and antioxidative activity","volume":"28","author":"Park","year":"2007","journal-title":"Bull. Kor. Chem. Soc."},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2024.135761_bb0930","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.phymed.2006.09.001","article-title":"Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr","volume":"14","author":"Wirasathien","year":"2007","journal-title":"Phytomedicine"},{"issue":"04","key":"10.1016\/j.ijbiomac.2024.135761_bb0935","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1142\/S0192415X08006247","article-title":"Aldose reductase inhibitors from Viola hondoensis W. Becker et H boss","volume":"36","author":"Chung","year":"2008","journal-title":"Am. J. Chin. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0940","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1248\/bpb.31.1626","article-title":"Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts","volume":"31","author":"Lee","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.135761_bb0945","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.fct.2009.08.014","article-title":"Quantitative HPLC analysis of two key flavonoids and inhibitory activities against aldose reductase from different parts of the Korean thistle, Cirsium maackii","volume":"47","author":"Jung","year":"2009","journal-title":"Food Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0950","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1211\/jpp.60.9.0016","article-title":"Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts","volume":"60","author":"Jung","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.135761_bb0955","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12272-011-0205-1","article-title":"Inhibitory effect of glucodistylin from the bark of Quercus acutissima on human recombinant aldose reductase and sorbitol accumulation","volume":"34","author":"Lee","year":"2011","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb0960","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1248\/cpb.43.920","article-title":"Inhibitory effect of perillosides A and C, and related monoterpene glucosides on aldose reductase and their structure-activity relationships","volume":"43","author":"Fujita","year":"1995","journal-title":"Chem. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0965","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1248\/cpb.45.1306","article-title":"Aldose reductase inhibitory constituents of the root of Salvia miltiorhiza Bunge","volume":"45","author":"Tezuka","year":"1997","journal-title":"Chem. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.135761_bb0970","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/np0301543","article-title":"Structures of new friedelane-type triterpenes and eudesmane-type sesquiterpene and aldose reductase inhibitors from Salacia chinensis","volume":"66","author":"Morikawa","year":"2003","journal-title":"J. Nat. Prod."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.135761_bb0975","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.bmc.2005.10.013","article-title":"Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. Hirtum","volume":"14","author":"Koukoulitsa","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb0980","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.fitote.2010.06.025","article-title":"Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum","volume":"81","author":"Fatmawati","year":"2010","journal-title":"Fitoterapia"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb0985","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1248\/bpb.17.458","article-title":"Studies of anti-cataract drugs from natural sources. I. Effects of a methanolic extract and the alkaloidal components from Corydalis tuber on in vitro aldose reductase activity","volume":"17","author":"Kubo","year":"1994","journal-title":"Biol. Pharm. Bull."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.135761_bb0990","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1021\/jf020674o","article-title":"Rat lens aldose reductase inhibitory activities of Coptis japonica root-derived isoquinoline alkaloids","volume":"50","author":"Lee","year":"2002","journal-title":"J. Agric. Food Chem."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2024.135761_bb0995","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.phymed.2007.04.008","article-title":"Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity","volume":"16","author":"Kato","year":"2009","journal-title":"Phytomedicine"},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.135761_bb1000","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/0929867033457304","article-title":"Aldose reductase inhibitors from the nature","volume":"10","author":"Kawanishi","year":"2003","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb2000","doi-asserted-by":"crossref","first-page":"817","DOI":"10.11002\/kjfp.2011.18.6.817","article-title":"In vitro antioxidant activity of the aqueous of Angelicae gigas Nakai leaves","volume":"18","author":"Park","year":"2011","journal-title":"Korean J. Food Preserv."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.135761_bb1005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/np020058m","article-title":"New flavonol oligoglycosides and polyacylated sucroses with inhibitory effects on aldose reductase and platelet aggregation from the flowers of Prunus mume","volume":"65","author":"Yoshikawa","year":"2002","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.135761_bb1010","first-page":"226","article-title":"Inhibitory activity of Cinnamomum cassia bark-derived component against rat lens aldose reductase","volume":"5","author":"Lee","year":"2002","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.135761_bb1015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1248\/bpb.28.1103","article-title":"Aldose reductase inhibitors from the fruiting bodies of Ganoderma applanatum","volume":"28","author":"Lee","year":"2005","journal-title":"Biol. Pharm. Bull."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024065693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024065693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:47:35Z","timestamp":1782780455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024065693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":204,"alternative-id":["S0141813024065693"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135761","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"135761"}}